A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) ...
The ability to measure brain functions non-invasively is important both for clinical diagnoses and research in neurology and psychology. Two main imaging techniques are used: positron emission ...
Ingelheim, Germany, 3rd September, 2012 – New phase II data presented for the first time today at the 2012 European Respiratory Society (ERS) congress show that combining tiotropium with olodaterol ...
Further tiotropium + olodaterol FDC data on patient outcomes such as quality of life are due to report later this year SAN DIEGO--(BUSINESS WIRE)--For media outside of the US, the UK & Canada only ...
New research has demonstrated that a combined regimen of growth hormone and testosterone is safe, well-tolerated, and is ...
Boehringer Ingelheim announced results from the Phase 3 VIVACITO study evaluating the effect of the fixed-dose combination of tiotropium and olodaterol (T + O FDC) delivered via the Respimat inhaler, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback